Resources

FEATURED VIDEO

Revolutionizing Metabolomics  

Enhanced LC-MS Annotation using Pyxis

News & Press Releases

DECEMBER 2024

Pyxis™ Receives The Analytical Scientist Innovation Award 2024

Matterworks receives The Analytical Scientist Innovation Award 2024 for Pyxis, a "smart application of AI for the analysis of LC-MS data."

ARTICLE

JUNE 2024

Matterworks Launches Pyxis™ - First AI-Powered, Turn-Key Platform for Identification and Absolute Quantitation from Mass Spectrometry Data

Matterworks is pleased to announce the official launch of Pyxis, our AI-powered platform for untargeted absolute quantitation of analytes.

ARTICLE

MAY 2024

Matterworks Announces Updates to Leadership Team

Matterworks is pleased to announce the appointments of Jennifer M. Campbell, Ph.D. to the position of Chief Scientific Officer and Niall O'Connor to the position of Chief Technology Officer.

ARTICLE

FEBRUARY 2024

Matterworks Announces Board Updates

Matterworks is pleased to announce the appointments of Michael Lavin, a Managing Partner at Germin8 Ventures and Dr. Shubhra Jain, Head of Health-Tech Venture Investments at Tarsadia, as Board Members.

ARTICLE

MARCH 2023

2023 Life Science Review Award

Matterworks has been recognized in the Top 10 Biotech Startups - 2023 by Life Science Review.

ARTICLE

DECEMBER 2022

Matterworks Announces CEO Appointment and Board Updates

Matterworks, Inc., developers of the world’s most powerful AI platform for modeling real-time biology to accelerate the discovery, development, and manufacturing of life sciences technologies, including biologics and gene therapies, today announces CEO appointment and updates to its Board of Directors.

PRESS RELEASE

AUGUST 2022

Matterworks Awarded NIIMBL Project 5.2 Grant

Matterworks is awarded a grant to participate in NIIMBL Project 5.2. With support from Eli Lilly and Sartorius our novel AI-powered Pyxis™ Metabolomics Platform will demonstrate biological insight in bioprocessing through the rapid, absolute quantitation of critical metabolites that impact titer and CQAs.

ARTICLE

APRIL 2022

Matterworks Announces Updates To Its Board Of Directors

Matterworks, Inc., developers of the world’s most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.

PRESS RELEASE

Product Literature

Website - Resources Thumbnail - 750x394 px 15

 

Preprint: LSM1-MS2: A Foundation Model for MS/MS, Encompassing Chemical Property Predictions and de novo Generation

Read our preprint about Matterworks' LSM1-MS2, a pre-trained self-supervised foundation model for tandem mass spectrometry (MS/MS).

PDF

Website - Resources Thumbnail - 750x394 px 11

 

Revolutionizing Metabolomics: AI Meets Mass Spectrometry

Download an editorial summary about our webinar hosted by The Analytical Scientist featuring Matterworks CSO Jennifer Campbell and Dr. Naama Kanarek.

PDF

 

Website - Resources Thumbnail - 750x394 px 14

 

Preprint: A scalable approach to absolute quantitation in metabolomics

Read our preprint authored in conjunction with collaborators from Boston Children's Hospital and Harvard Medical School.

PDF

 

An image of the Pyxis logo with the application brief title and summary text

 

Using Pyxis for the Characterization of Microbiome Function

An application brief explaining how Pyxis can be used for absolute quantitation of untargeted small-molecule messenger analytes to elucidate microbiome function.

PDF

Website - Resources Thumbnail - 750x394 px - Infographic

 

Infographic: Navigate Your Way to Precise and Scalable Untargeted Metabolomics

An infographic that highlights the advantages of absolute quantitation over relative quantitation and explains how Pyxis enables absolute quantitation.

PDF

Website - Resources Thumbnail - 750x394 px - mana

 

High Throughput Metabolite Quantification in Biological Samples with Pyxis, a Matrix-Agnostic AI/ML Tool

A poster authored by Sofia Costa, PhD,  Principal Scientist at Matterworks. Presented at Metabolomics Association of North America (MANA) 2024.

POSTER DOWNLOAD